TURBOCAR Trademark

Trademark Overview

On Wednesday, January 8, 2020, a trademark application was filed for TURBOCAR with the United States Patent and Trademark Office. The USPTO has given the TURBOCAR trademark a serial number of 88751692. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, January 20, 2023. This trademark is owned by Allogene Therapeutics, Inc.. The TURBOCAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
turbocar

General Information

Serial Number88751692
Word MarkTURBOCAR
Filing DateWednesday, January 8, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, January 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, January 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, January 20, 2023ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, January 20, 2023ABANDONMENT - AFTER PUBLICATION
Thursday, January 19, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 4, 2022SOU EXTENSION 5 GRANTED
Wednesday, October 26, 2022SOU EXTENSION 5 FILED
Friday, November 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 4 GRANTED
Monday, April 25, 2022SOU EXTENSION 4 FILED
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2021SOU EXTENSION 3 GRANTED
Wednesday, November 10, 2021SOU EXTENSION 3 FILED
Wednesday, November 10, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 2 GRANTED
Thursday, April 15, 2021SOU EXTENSION 2 FILED
Thursday, April 15, 2021SOU TEAS EXTENSION RECEIVED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Thursday, November 5, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 6, 2020ASSIGNED TO EXAMINER
Monday, January 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 11, 2020NEW APPLICATION ENTERED

Related Keywords

turbocar preparations pharmaceutical including therapy immunotherapy cell tumors namely treatment cancer